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In our fast-paced society, numerous .emotional and
physiological factors often produce stress, anxiety,
depression, and other dysfunctional behavior. One of
the significant stressors that appear regularly where
there are family and/or emotional problems is the use
and abuse of drugs and substances which affect the
central nervous system (brain and spinal cord). These
agents can include prescribed drugs improperly taken,
over-the-counter drugs purchased at local pharmacies
or grocery stores, or illicit substances ingested for the
"high" they seem to provide. However, when utilized
and administered by competent medical personnel, these
agents offer excellent palliation for psychopathology.
The therapeutic use of pharmacologically active drugs
for behavioral dysfunctions requires competent
diagnostic skills, expertise in clinical pharmacology, and
proper monitoring techniques. Each involves years of
preparation and training and are far beyond the scope of
this paper. Within this context the author seeks to
provide the reader with a survey of the major
classifications of frequently prescribed and/or abused
drugs only as a reference.
There have been many attempts in the literature to
categorize and segment psychoactive agents. These
attempts have varied, depending upon the reason for
classification, from pharmacological approaches to
pathological approaches to therapeutic approaches. All
have merit and clearly show that any attempt at drug
classification is, at best, superficial. Add to these
attempts the ever-increasing abuse problem with
psychoactive agents, and the problem of categorizing
these agents becomes even more formidable.
For this paper the agents are classified into three
categories (Table 1) utilizing a pharmacological approach
and taking the chemical structure into consideration.
Major drugs of abuse have been included to show action
correlation. It must be kept in mind, however, that
agents placed in one category can and do therapeutically
and pathologically fall into other categories.

c. Oxymorphone (Numorphan)
d. Methyldihydromorphinone (Metopon)
e. Codeine
f. Hydrocodone (Dicodidl
g. Oxycodone (Percodan)
2. Phenylheptylamines
a. Methadone (Dolophine)
b. Propoxyphene (Darvon)
3. Phenylpiperidines
a. Meperidine (Demerol)
b. Alphaprodine (Nisentil)
c. Anileridine (Lentine)
d. Piminodine (Alvodinel
e. Diphenoxylate (in Lomotil)
4. Morphinans
a. Levorphanol (Levo-Dromoranl
b. Methorphan
c. Levallorphan (Lorfan)
5. Benzomorphans
a. Phenazoci'"e (Prinadol)
b. Pentazocine (Talwip)
B. HYPNOTIC·SEDATIVES
1. Barbiturates
a. Ultra short acting
Thiopental (Pentothal Sodium)
b. Short acting
Pentobarbital (Nembutal)
Secobarbital (Seconal)
c. Intermediate acting
Amobarbital (Amytal)
d. Long acting
Phenobarbital
Mephobarbital (Mebaral)
Metharbital (Gemonil)
2. Non-barbiturates
a. Tertiary carbinols
Ethchlorvynol (Placidyl)
Ethinamiate (Valmid)
b. Piperidinediones
Glutethimide (Doriden)
Methyprylon (Noludarl
c. Chloral derivatives
Chloral hydrate (Noctecl
Chloral betane (Beta-Chlor)
Traclo!os (Triclos)
d. Quinazolones
Methaqualone (Qualude)
e. Monoureides
Paraldehyde (Paral)
Acetylcarbromal (Paxarel, Sedamyl)
3. Phencyclidine
11-(Phenylcyclohexyl) piperidine I
C. TRANQUILIZERS
1. Neuroleptics (antipsychotics or major tranquilizers)
a. Phenothiazines
1) Aliphatics (Aminoalkyls)

TABLE 1
Outline of Draa Cbssiflalion
I. CNS DEPRESSANTS
A. NARCOTIC ANALGESICS
1. Natural and semisynthetic opiate alkaloids
.
a. Morphine
b. Hydromorphone (Dilaudid)

*Brother Woolley is Director of the BrighilDl Young
University Health Center.
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1. Amphetamines

Promazine (Sparine)
Chlorpromazine (Thorazine)
Triflupromazine (Vesprin)
2) Piperidines
Thioridazine (Mellaril)
Mesoridazine (Serentil)
Piperacetazine (Quide)
3) Piperazines
Prochlorperazine (Compazine)
Trifluoperazine (Stelazine)
Butaperazine (Repoise)
Acetophenazine (Tindal)
Fluphenazine (Prolixin)
Perphenazine (Trilafon)
Carphenazine (Proketazine)
b. Thioxanthenes
Thiothixene (Navane)
Chlorprothixene (Taractan)
c. Butyrophenones
Haloperidol (Haldol)
d. Dibenzoxapines
Loxapine (loxitane)
e. Indoles
Molindone (Lidone, Moban)
f. Rauwolfia alkaloids
2. Anxiolytics (minor tranquilizers)
a. Diphenylmethane antihistamines
Diphenhydramine (Benadryl)
Hydroxyzine (Vistaril. Atarax)
b. Propanediol carbamates
Meprobamate (Equanil. Miltown)
Tybamate (Solacen)
c. Benzodiazepines
Chlordiazepoxide (Librium)
Diazepam (Valium)
Prazepam (Centrax)
Chlorazepate Monopotassium (Azene)
Chlorazepate Dipotassium (Tranxene)
Alprazolam (Xanax)
Clonazepam (Clonopin)
Flurazepam <Dalmane)
Lorazepam (Ativan)
D. ANTIPARKINSONIAN AGENTS
1. Anticholinergics
Ben~otropine (Cogentin)
Trihexyphenidyl (Artane)
Procyclidine (Kemadrin)
Cycrimine (Pagitane)
Biperiden (Akineton)
Ethopropazine (Parsidol)
2. Antihistamines
Diphenhydramine (Benadryl)
Chlorphenoxamine (Phenoxene)
Orphenadrine (Disipal)
3. Miscellaneous
Amantadine (Symmetrel)
. E. ALCOHOL
II. CNS STIMULANTS (THYMOLEPTICS)
A. XANTHENE ALKALOIDS (PURINES)
1. Theophylline
2. Theobromine
3. Calfeine
B. ECGONINE DERIVATIVES
1. Cocaine
2. Misc. atropine-like compounds
C. PHENYLETHYLAMINES
(SYMPATHOMEMETIC AMINES)
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2. Other
J1J, MOOD MODIFIERS
A. ANTIDEPRESSANTS
1. Monoamine oxidase (MAO) inhibitors
a) Hydrazines
Iproniazid (Marsilid)
b) Nonhydrazines
Tranylcypromine (Parnate)
2. Tricyclic antidepressants
a. Dibenzazepine derivatives
Imipramine (Trofranil)
T rimipramine (Surmontil)
Desipramine (Norpramin, Pertrofrane)
b. Dibenzocycloheptadiene derivatives
Amitryptyline (EIavil)
Nortriptylene (Avenlyl)
Protriptylene (Vivactil)
Doxepin (Adapin,Sinequan)
3. T etracyclics
Maprotiline (Ludiomil)
4. Miscellaneous
Amoxapine (Asendin)
B. LITHIUM
C. PSYCHOTOMIMETICS
(HALLUCINOGENS, PSYCHODYSLEPTICS)
1. Mescaline
2. Psylocibin
3. Lysergic acid derivatives
4. Tryptamines
5. Cannabis (marihuana)

Central Nervous System Depressants (psycholeptics)
Generally, excluding the anesthetics, the CNS
depresssant substances can be divided into five divisions:
the narcotic analgesics and antagonists, the sedativehypnotics, the tranquilizers, the antiparkinson agents,
and alcohol.
Narcotics
These drugs (Table 2) depress the centers in the brain
and spinal cord and are used medically as analgesics
(agents to relieve pain) as well as for their antitussive
(cough relief) properties. They have a high potential for
producing physiological and psychological dependence.
Tolerance' develops quite rapidly with these agents, and
cross-tolerance 2 exists in this category. The narcotics
are divided into the natural and semisynthetic opiate
alkaloids.
The opium alkaloids are contained in a white milky
substance obtained from the unripe bulb of the poppy
(Papaver somniferum). The milky substance expelled
contains many drugs, including morphine, codeine,
ethylmorphine, apomorphine, and papaverine.
Morphine is the most important alkaloid; however,
codeine is the most widely used.
1. Tolerance is a resistance and/or accommodation that is developed

to the effects of the drug as that drug is chronically ingested. As •
result of tolerance, over a prolonged period of time, more of the
drug is needed to get the same effect one experienced with the
initial dose.
2. CrQss-tolerance refers to a condition in which tolerance toone kind
of drug builds up and is carried over to other drugs. Drugs in many
categories exhibit this property within their particular drug family.
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development of dependence. They are classified by their
chemical structure and include the tertiary carbinols
(Placidyl, Valmid), the piperidinediones (Doriden,
Noludar), chloral derivatives (chloral hydrate), the
quinazolones (Quaaludel, and the monoureides (Paral,
Paxarel). They are used in medical practice to induce
sleep.

TABLE 1
Commonly Us~ NarcotiC'S

•
Proprietuy NU''le

Opium
Morphine

Generic N.me

Codrine

Morphine Sulf,te
Codeine Phosph,te

Heroin
Dilfudid e
Perroc"n-

Hydromorphine
Oxycodone HCI

Demer~e

OoIophine-

Usu,l Sinsle
Aduh Dou~e

Meperidine
Meth,done

Dur.tion
of Action

2m,

S hrs_
4 hrs.
4 hrs.
2-3 hrs.
4 hrs.

ISmS
30-6sm.

I t.blel

'" hrs.

SO-100m.

4 hrs.

5-10 m,

4 hrs.

TABLE 4
Nonbubitur..tes

Doriden s

Many.other agents have been developed to produce
analgesic and antitussive properties similar to the opiate
alkaloids without the problem of dependency. However,
dependency has proven to be a problem with all of these
agents.
Usual short-term effects include sedation, analgesia,
euphoria, and impaired intellectual functioning and
coordination. Chronic effects include constipation, loss
of weight and appetite, and temporary impotency or
sterility together with dependence and tolerance.
Sedative-Hypnotics
One group of sedatives and hypnotics are derivatives
of barbituric acid and are referred to as barbiturates.
They induce a high degree of both physiological and
psychological dependence and tolerance develops quite
rapidly. Barbiturates (Table 3) are divided into four
groups by their duration of action. The ultra shortacting barbiturates, such as thiopental (Pentothal), act
very rapidly and have a duration of roughly an hour,
depending upon the individual. The short-acting
barbiturates, such as pentobarbital (Nembutal) and
secobarbital (Seconal), react at a slower rate and have a
duration of around three to four hours. The
intermediate-acting barbiturates such as amobarbital
and butabarbital have a duration of action between four
and six hours. The classic example of long-acting
barbiturates is phenobarbital, which has a duration of
five to eigh t hours.

PbodylS

Dur..ion
ProduCl

Uhruhort II hour)
Short (.) hours)

Thiopent,l (Penloth,I-J
Secob,rbit,IISecon,le,

Inlermf'di,te

Penlob,rbit,l fNembul"-'
Bul,b.,bit,1 fButilOle)
Amobubit.. i (Amyt.. I-)

(4·6 houn)

Lona (More
th,n 6 hOuri)

Phenob.rbit.1
B.. rbit.1 (Veron,I-)

Quuludea

Ethchlorvynol
Meeth,qu..lone

Noclec·
Nolud.. ra

Chlor.. 1 hydr.. te
Melhprylon

Dur.. tion
of Action

0500 ma "blels

.5hrs

.nd upsules
sao ma t.blets
1.50·)00 ma
upsules
leo m~ upsules
laO ma upsules

S hrs.

Usual short-term effects of the barbiturates and
non barbiturates include relaxation and sedation,
drowsiness, sleep induction, euphoria, impaired
judgment and reaction time and, to some degree, muscle
relaxation. Chronic effects include irritability and
weight loss as well as dependency.
Another sedative-hypnotic agent is a drug
synthesized in 1957 called phencyclidine (Sernyl,
Sernylan). During clinical trials it soon became apparent
that the adverse effects of agitation, disorientation, and
hallucinatory phenomena precluded its use in humans.
Since that time, phencyclidine has been available for
legitimate use only as a veterinary sedative and hypnotic
for primates.
On the streets, it is called "PCP" or the "peace pill."
Recently, it has been called "angel dust." This agent is
extremely toxic in large doses, and the illegally produced
thiophene analog appears to be even more toxic.
Tranquilizers
Another subcategory of central nervous system
depressants is tranquilizers. The tranquilizers are
divided into two basic groups, the neuroleptics and
anxiolytics, and are used medically in the treatment of
psychoses and neuroses.
The neuroleptics (major tranquilizers or
antipsychotics) include (1) the phenothiazines-including the aliphatics, the piperazines, and the
piperidines; (2) the thioxanthenes, such as
chlorprothixene (Taractan) and thiothixene (Navene);
(3) the butyrophenones, such as haloperidol (Haldol),
whose action resembles that of the piperazine
phenothiazines; (4) the in doles, such as molindone
(Moban); and (5) the dibenzoxapines such as loxapine
(Loxitane) and chlozapine. The neuroleptics are used to
treat the psychoses.
The major drug-induced aclverse reactions from
neuroleptics are called extrapyramidal symptoms and
are generally broken down into five distinct disorders or
syndromes:
1. Tardive dyskinesia (Table 5) is a hyperkinetic

TABLE .)
Commonly UHd B.ubltur.ltn

of Action

Gh.tethimide

Usu.. 1 SinKle
Adult Dose

Hypnollc Dot.e

0.1-0.2 1m

O.la m
0.1·0.2 am
o.OS-O.la m

0.1-0.2 1m
0.3-a.Ssm

Another group of sedatives and hypnotics (Table 4) is
similar in action to the barbiturates, but is not a
derivative of barbituric acid. In the past there was some
question about whether these drugs produce real
physiological. dependence; however, as new data
becomes available, evidence now points to a
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TABLE.
Acut.. Dystonic R...tIOM

disorder developed by some patients. on long-term
antiphsychotic therapy (particularly phenothiazines)
which appears and persists after drug withdrawal. This
disorder, at least at present, seems to be irreversible.

•

I.
2.

TABLE .5
Tudlvt' O)'lkln"',

I.

Incidence m.y

~

3.
4.
.5.
~.

u hilh u 1S·20"t0.

2. .Occurs mort' oEtrn in elderly p",tients. lr'pKi.lly ,hOJr with .. hIStory of br.ln d.lm.&t'.
J. Moay not b«OfM .p~r.nl unhl the .ntiptychollc druB is IIOpP'f'd or Iht' dOH' rf'duCH
4. Chu.cleflud by Itt'rfOly~ mOYt'mtflts of Iht' lips .nd lon~u•• nd wmelime, of the

The anxiolytics (minor tranquilizers) (Table 9) can
lead to a psychological and physiological dependence,
and tolerance is developed. They are divided into three
groups: (1) the propanediol carbamates, (2) the
diphenylmethane derivatives, and (3) the
benzodiazepines. Most common short-term effects
include drowsiness and fatigue. Effects of chronic
ingestion include insomnia, delusions, and anxiety.

trunk or ."In'mili.,.

5.

Anllpolrk!",,," droIt m.. k. II more ~Y .. re. Symptoms ue luu·ne-d by .nllpsycholtc

b.

OUr.ltion of dlsord.r molY ~ from WH", 10

mf'd,c.tion.
7.

SHn in only .Ibout 2-. of tr....lt'd plli..n1'.
U,u,lIy .un within 14-48 houn .. hlE'r dNa adminiltr.lton hu bnn in,UtutN. Nl..... ty
ptrc..nt of IhlE' curt occur within 4 1/1 d.. y,.
Sun morl!' ofllE'n in m.I.., under Iht' 'St' of 40 .nd in children.
Sten more lrfllut'nlly with piptr'linl!' phl!'nothi.linlft .nd wilh h.klp.,idol.
Ch"Ktt'm..d by oculoayric crili•. torticollis.•nd protrutMM of IN 1onlulE'.
RlE'sponds well to Irl!'.Ilml!'nt with .50 mR 01 hn.-dryl.

yr,".
Possibly dut' 10 .Irv.tf'd ,.nlr,,1 level, of dop.mlnt'

2. Akinesia (Table 6) is a drug-induced disorder
characterized by muscle rigidity and weakness.

TAlLE 9

TABLE'
Akln"l,

2
3.
4.

Srlmed Anxlolytk Apnb

Occurs ,n .bout 15"- of p.lM-n'S 'rto",tf'd With .nIlPl)'chohC drUB' 'n 90".. of Ih.. US" It
occurs within th. finl 71 hours of ',•• Imenl.
Occun more fre-qut'ntly In f.m.lu Gvrr olaf' so ,nd morlE' ohlE'n WIth IhlE' .1,ph'hC lyplE' ul
phlE'nolhiuinlE's .nd butyrophl!'non".
Ch,u.cll!'riud by. m.uldikl!' I.cl!'. rf'dueed um movcml!'nl.shulfllnl B.,I, .nd rulhnM h.nd
movl!'ml!'nl •.
Rudily conlrollf'd wilh tr,dllion.1 .nliplrl..in,un dru81

rrC'p'lri.lry N.. _

Gt-fWric N.. _

Equ.nll·
Millown-

MlE'proNlNlt'

400 m8 I",bfell

Ml!'p,ob.ItNt..

400

D,rll",,,,I,,,,...., A.."l,.,~",,'lI('
Hydrollyzint'
1'.l.lr.... -.\'"I.ril·
Llbflum·

ChlordunpolKt'

\·.llum·

(A.lle~m

100 ml , ..bMIs

SlE'rn-

(huep.un

.5-10 ml up'uln

2me.''''810

Inddl!'nee of .Ibout 2t ..... 'Hn Al!'nlE'ully .hl!'r .. 'lE'w wnl..l oJf Ihl!'upy
Inddl!'ncl!' is hi~htr '" yuunA fl!'m.ll!'l.
Ch"ull!'riud by .In in.bihly to III ur II.nd still OnHt is ohl!'n prt'Ct'df'd by muKul"
dlscomlort.
Rl!'spondl rudily h' lriE'.tmiE'nt wilh l,.dillon..1 .nhp,,}.,n$OJ\ drugs.
SI!'t'n moriE' fr~uiE'nlly wllh ptPlE'rn'nt' phlE'no.llhl.. lInt's

CIOr.lzepoillf
o.polu1ium

hn.

4h~

5hn
4-' hn.

ms t.lbkt.

IOma.l.5ma

3.7S rna,. 7..5 ml-

4-5 hr...

4-' hn..

rna "p'uln

15 mit "p'uWs

Alcohol
Another category of depressants commonly used is
alcohol. Usual short-term effects include central
nervous system depression and impaired judgment,
coordination, and reaction time. Chronic ingestion
effects include possible obesity and irreversible damage
to the brain and liver.

4. Dystonic reactions (Table 8). The dystonias are
acute disorders of muscle coordination, particularly in
the face--e.g., grimaces, protrusion of the tongue,
dysarthrias (imperfect articulation of speech), and
oculogyric crisis 1. Other symptoms include tics,
opisthotonos 2 , and torticollis'.
s. Dyskinesia is an acute disorder characterized by the
impairment of the power of voluntary movement. This
impairment results in fragmentary or incomplete
movements.

Central Nervous System Stimulants (Thymoleptics)
The central nervous system stimulants can be divided
into three main divisions: the xanthine alkaloids
(purines), the ecgonine derivatives, and the
phenylethylamine sympathomimetic amines.
The xanthine alkaloids (purines) include theophylline,
theobromine, and caffeine. Usual short-term effects
include central nervous system stimulation, reduction of
fatigue, and diuresis. Chronic ingestion and abuse
dosages elicit such effects as insomnia, tolerance, and
psychological dependence.
Ecgonine derivatives include cocaine and other
miscellaneous atropine-like compounds. They are
included here because of their high abuse and
psychotoxic potential. Cocaine is obtained from the
leaves of Erythroxylon coca trees and other species of

1. Oculogyric crisis is an adverse reaction to antipsychotic medication
that is characterized by a sudden turning up of the eyeballs. The
patient is unable to move them and experiences severe pain due to
the muscle spasms of the eye.
2. Opisthotonos - when a person's back muscles go into spasms
causing his head and feet to bend backward and his torso to arch
forward.
3. Commonly called wry n«k, torticollis is a unilateral spasm of neck
muscles. The IT'!ost easily recognized symptom is the turning of the
head to one side.
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4

4 hn.

JO rna uptu....

15

s

ms r",bI..u

2.5ma o ps.u1n

Tr,nllel'll!'·

..I.

01 Anion

8A:#OI'eur"I""

TABLE 1
Alullhl'....

1.

Dur.hCMt

Adul,~

rr",...",.J,ou

3. Akathisia (Table 7) is the name for a condition of
inner disquiet accompanied by an uncontrollable motor
restlessness. The most frequently observed symptom is
the patient's inability to sit or lie quietly.

2
3.

Vt"",ISlnlM-
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Erythroxylon. These trees are indigenous to Peru and
Bolivia and have been used by the natives for centuries
to increase endurance. There are many plants growing
freely in almost all climates that are related to this
alkaloid.
The third category includes the phenylethylamine
sympathomimetic amines (Table 10). The major group
of agents in this category is the amphetamines, but must
also include other phenylethylamines with action similar
to that of the amphetamines.
These agents have a potential for inducing both
psychological and physiological dependence and they
develop tolerance. Current medical uses include the
treatment of narcolepsy and as a therapeutic agent for
hyperkinetic children.

to moderate psychological dependence, and tolerance
can develop. It should be pointed out that even though
these drugs are classified as "hallucinogens," they do not
cause true hallucinations every time they are used.
Many times they cause the person who abuses these
substances to perceive the environment in a distorted
form--synesthesia, not strictly hallucination. The
psychotomimetics can be classified into four agents or
groups of agents. These are mescaline. psylocibin,
lysergic acid derivatives, and the tryptamines.
TABLE 11
Psychotomimetics (HallucinOiens or Psychodysleplics)

Usual SinJtle

Durati~ln

Cheminl Name

Adult Dose

of Achon

LSD

LyMrSK acid

150-"'00 mit

111'1"

Psylocibin

dirthy"mide tartralll'
Dimethyl .....

I j InJt

3hn.

OJethyllryp.amlne

0.7 mltJkJt

1/1-1hrs.

Dimethyltryptamlnr

0_1 mit/kit

112·2hn.

100 mit

12hn

Common Name

TABLE 10

Phnlylethylaminn (Sympathomimetic Aminn)

USWlI

Propri""y
N.....

~nudrint'·

Genene N.me
Amphet.. min..

sulf.,,,
Out'drin.. e

Didrl'lI e

Btphltl.llmin..-

Duution

Adult Dow

of Act.on

1.5-5.0

m~

~·o

hydro. y-Iryptamlne

DH
DMT
MDA

hno

IS mil:

OucrOoimphet.. mine

sulf.,..
Drumy'8

Sin~le

2.'·5.0 rnA

4·0

hn

phenrthy"mlnr

STP

"'-mrt"yl-2.S dime·
t"o:l:y-mrthylphl'nf'-

).2·10.0 mit

0·24 hrs,

"'0 nn.
4-0 hn.

t"y"mlnr
Tn mrt "Ol{y,u:l:yphrn.

112.·31-1 l1l or

Uhn.

rlhylaminr

0-12. bultons

ISml\:

Dtudrinl' .nd

.mob..,btt..1
8f'nzphltl.lminl'
R".n comptu", of
.. mphrt.. mln.. .-nd

2 ..5·.5.0 mil:
SO mJt
2.S-'.0 mil:

Peyotl'

-4-0 hn.

IMuuhnel

o.-yn·

Mt"lh"mphlrlolminl'

2 .5-S.0

m~

~·o

11'''' ""_ j •• ,l.r lit TIl..'

Phfnml'lrUlnl'

m~

"-0 hn

10-20 rnA

4-0 hrs

2.S-S.0

Mf.hylphl'ntCbll'

T..

hydrochloride
OifthylproptOn

2.'-'.0 mil:

lon.mi"-

hydrochloride
Ph..nl..rmin..

1$·30 mx

nlU'''·

mit

Mescaline is a pharmacologically active alkaloid from
various species of the cactus Lophophora. The top of the
aerial shoots is cut off and dried. the needles removed,
and what is left is called a peyote button or mescal
button. Mescaline is a phenylethylamine and has actions
similar to those agents.
Psylocibin comes from the sacred Mexican mushroom
(Psylocybe mexicana). It is an alkaloid with
phenylethylamine properties and is reported to be up to
100 times more potent than mescaline.
Lysergic acid derivatives are numerous. Many plants
including morning glory seeds and ergot, are precursors
to lysergic acid. Ergot comes from the rye plant in the
form of a copper-colored rust that grows around the top
when the plant remains too moist. The most commonly
abused lysergic acid analog is LSD (d-lysergic acid
diethylamide tartrate). The dose of LSD is 1140,000 gm.
Tryptamines are generally shorter acting than the
lysergic acid derivatives. Lysergic acid "trips" can range
up to a day in length. Tryptamines last two hours.
Dimethyltryptamine (DMT) is sometimes called
"businessman's trip" and lasts about 45 minutes.
Diethyltryptamine (DET) lasts about two hours and is
similar to DMT.
Usual short-term effects of the psychotomimetics
include visual imagery. increased sensory awareness,
anxiety, nausea, and impaired coordination and sensory
perception. Chronic ingestion effects are generally no
different from short-term effects; however, long-term
use has been shown to produce a more pronounced panic
reaction.
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Mood Modifiers
Antidepressants
Monoamint oridast (MAOI inhibitors. MAO inhibitors can
be divided into the hydrazines and the nonhydrazines.
They are used as antidepressants, and the dosage varies
with each individual agent. lsocarboxazid (Morplan) and
tranylcypromine (Parnate) are the most potent on a
milligram per milligram basis, and nialamide (Niamid) is
the least potent. MAO inhibitors have numerous
adverse effects including insomnia, hallucinations,
muscle weakness, headache, dryness of the mouth. and
blurred vision. Other effects include hypotensive
reactions, infrequent anorexia (loss of appetite).
hepatobiliary reactions, and inability to ejaculate.
Tricyclic antidtpmsants. Tricyclic antidepressants are
divided into the dibenzazapine derivatives (Tofranil and
Fertofrane or Norpramin) and the dibenzocycloheptadiene derivatives (e.g., Elavil and Aventyl). Another
compound, doxepin, (Sinequan) is closely related to the
dibenzocycloheptadiene derivatives.
Psychotomimetics (Hallucinogens or Psychodysleptics)
The psychotomimetics (Table 11) are agents with no
currently accepted medical use. They produce minimal
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CANNABIS (Marihuana)
Cannabis is not a narcotic, not a depressant, not a
stimulant, not a tranquilizer, and not '8 hallucinogen-although it has properites similar to each of these. In
animals, cannabis potentiates barbiturate sleep time. It
also potentiates amphetamine stimulation in animals.
All the agents listed under psychotomimetics have cross
tolerance; however, cannabis does not have crosstolerance with the hallucinogens.
Use of cannabis creates a moderate psychological
dependence, and it has moderate tolerance potential.
Cannabis is not a single substance. A number of
different varieties have been isolated. Examples of
various types include Cannabis sativa, Cannabis indica,
Cannabis americanus, and Cannabis mexicana.
Differentiation has been made between several varieties
such as michoacan, columbian, and synsimillia. These
varieties can have such a low potency that the person
ingesting the substance has almost no discernible effect.
On the other hand, there are some varieties that have
shown toxic manifestations in the nerve pathways in the
brain.
Usual short-term effects include relaxation, euphoria,
increased appetite, and possible impairment in
judgment, time perception, and coordination. Possible
long-term effects include subtle personality changes and
diminution of intellectual acuity.
Conclusion
The drugs or agents mentioned, as well as the
terminology presented, are given as an overview with
the expectation that there will be a closer health
professional team relationship. This closer relationship
can lead to more adequate understanding of and rapport
with patients who are being treated (or are otherwise
involved) with agents having an effect on mood,
perception, and behavior. This presentation is made
with the hope that better management and monitoring
of the patient will occur to reduce possible drug sIde
effects and adverse reactions or interactions.
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